Why Do TTR Silencers Require Vitamin A Supplements?
At a Glance
TTR silencer therapies for ATTRv amyloidosis reduce the transthyretin protein, which normally transports Vitamin A in the blood. This reduction can cause a severe Vitamin A deficiency and night blindness. Patients must take a daily Vitamin A supplement to protect their vision.
In this answer
3 sections
If you are taking a TTR silencer therapy—such as patisiran, inotersen, vutrisiran, or eplontersen—you are required to take a daily Vitamin A supplement because these medications inadvertently remove your body’s natural transportation system for Vitamin A [1][2][3].
The Biology: Transthyretin and Vitamin A
To understand why this happens, it helps to look at the name of the protein itself. Transthyretin (TTR) gets its name from its main job in the body: it Transports thyroxine (a thyroid hormone) and retinol (Vitamin A). Under normal circumstances, the TTR protein safely carries Vitamin A through your bloodstream so it can be delivered to tissues that need it, like your eyes.
TTR silencer medications are designed to drastically reduce the liver’s production of the TTR protein, which is necessary to stop the toxic amyloid buildup that causes ATTRv amyloidosis [4][5]. However, by severely reducing the amount of TTR in your blood, the medication also eliminates the primary carrier for Vitamin A [1][2][3]. Without its dedicated transport protein, Vitamin A is quickly lost from the bloodstream, leading to a significant drop in Vitamin A levels [2][6].
The Risk: Night Blindness and Eye Health
Without consistent supplementation, the sharp drop in Vitamin A puts you at a high risk for developing a deficiency [2]. Vitamin A is absolutely essential for maintaining healthy vision, particularly the cells in the retina that allow you to see in low-light conditions.
A severe deficiency can lead to ocular issues, most notably nyctalopia (night blindness), which makes it difficult or impossible to see in the dark [7][8]. It can also cause severe dry eyes and physical damage to the structures of the retina [7][9]. Fortunately, if these vision issues occur, they are often reversible when caught early and treated with proper Vitamin A supplementation [10][11]. If you notice any changes in your low-light vision, tell your doctor or ophthalmologist right away.
Managing Your Supplementation Safely
Because the risk to your vision is significant, clinical guidelines mandate daily Vitamin A supplementation for anyone on a long-term TTR silencer (often around 2,500 to 3,000 IU/day, depending on the specific drug) [2][6].
When managing your supplements, keep the following safety guidelines in mind:
- Do not rely on blood tests: It is incredibly important to stick to the exact daily dose recommended by your doctor, and to avoid taking more. Blood tests to check Vitamin A levels are unreliable while on these medications. Because you are missing the transport protein, your blood levels of Vitamin A will always appear artificially low on lab tests, even if your body’s tissues have plenty.
- Avoid overdosing: Trying to raise your blood levels by taking higher doses of Vitamin A can lead to toxic and dangerous overdoses. Always follow your medical team’s specific dosing instructions and report any vision symptoms rather than relying on blood work.
- Take with food: Vitamin A is a “fat-soluble” vitamin. This means it requires dietary fat to be absorbed properly by your body. You should take your supplement with a meal or snack that contains some fat.
- Check your multivitamins: Because Vitamin A is stored in the body, taking too much can cause harm, particularly if you are pregnant or planning to become pregnant. Check the labels of any daily multivitamins you take, as they often contain additional Vitamin A, and discuss the total amount with your doctor.
Common questions in this guide
Why do TTR silencer medications cause Vitamin A deficiency?
Can I use blood tests to check my Vitamin A levels while on a TTR silencer?
What are the signs of Vitamin A deficiency while on ATTRv treatments?
How should I take my Vitamin A supplement for the best absorption?
What happens if my daily multivitamin also contains Vitamin A?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my specific TTR silencer therapy, what daily dose and form of Vitamin A do you recommend?
- 2.How do we handle my current daily multivitamin, which already contains Vitamin A?
- 3.Should I schedule proactive, regular visits with an ophthalmologist, or just wait until I notice low-light vision changes?
- 4.If I begin to experience difficulty seeing at night or severe dry eyes, what are our immediate next steps?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Patisiran for the Treatment of Transthyretin-mediated Amyloidosis with Cardiomyopathy.
Ioannou A, Fontana M, Gillmore JD
Heart international 2023; (17(1)):27-35 doi:10.17925/HI.2023.17.1.27.
PMID: 37456349 - 2
Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis.
Nie T, Heo YA, Shirley M
Drugs 2023; (83(15)):1425-1432 doi:10.1007/s40265-023-01943-z.
PMID: 37728865 - 3
Two Sides of the Same Coin: Transthyretin (TTR) as a Target or Drug Carrier for Drug (Bio)conjugates.
Russomanno P, Fragai M, Brindisi M, Pelliccia S
Journal of medicinal chemistry 2026; (69(3)):1803-1841 doi:10.1021/acs.jmedchem.5c01560.
PMID: 41627906 - 4
Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA, Witzigmann D, Chen S, et al.
Accounts of chemical research 2019; (52(9)):2435-2444 doi:10.1021/acs.accounts.9b00368.
PMID: 31397996 - 5
Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going.
De Michieli L, Lupi A, Sinigiani G, et al.
Journal of clinical medicine 2025; (14(10)) doi:10.3390/jcm14103481.
PMID: 40429476 - 6
A mutation in transthyretin gene in a Mexican patient leading to hereditary amyloidosis: a case report.
Malik MR, Dalia T, Shah Z
Journal of medical case reports 2025; (19(1)):384 doi:10.1186/s13256-025-05308-w.
PMID: 40760461 - 7
Night blindness, Bitot's spot and vitamin A deficiency.
Mishra K, Jandial A, Sandal R, et al.
QJM : monthly journal of the Association of Physicians 2019; (112(3)):225 doi:10.1093/qjmed/hcy218.
PMID: 30265370 - 8
Xerosis in Patient with Vitamin A Deficiency - a Case Report.
Kopecký A, Benda F, Němčanský J
Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 2018; (73(5-6)):222-224.
PMID: 30541304 - 9
Prevalence and Associated Factors of Clinical Vitamin A Deficiency Among Pre-School Children 1-5 Years of Age in Rural Kebeles in Farta District, South Gondar Zone, Ethiopia: A Mixed Methods Study.
Yisak H, Elmneh R, Taklual W, et al.
Journal of multidisciplinary healthcare 2020; (13()):1191-1201 doi:10.2147/JMDH.S279571.
PMID: 33116564 - 10
Case Report: Delayed Vitamin A Retinopathy Secondary to Bariatric Surgery.
Bhakhri R, Ridder WH, Adrean S
Optometry and vision science : official publication of the American Academy of Optometry 2019; (96(3)):227-232 doi:10.1097/OPX.0000000000001346.
PMID: 30801499 - 11
Outer retina changes on optical coherence tomography in vitamin A deficiency.
Berkenstock MK, Castoro CJ, Carey AR
International journal of retina and vitreous 2020; (6()):23 doi:10.1186/s40942-020-00224-1.
PMID: 32518692
This page provides educational information about Vitamin A supplementation during ATTRv amyloidosis treatment. Always consult your prescribing physician and ophthalmologist before starting, stopping, or adjusting any supplements.
Get notified when new evidence is published on ATTRV30M amyloidosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.